Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1986 Jun;22(2):114–118. doi: 10.1007/BF00199124

Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK

Sumiaki Tsuru 1,✉, Kikuo Nomoto 2, Mariko Taniguchi 1, Haruo Fujisawa 1, Yutaka Zinnaka 1
PMCID: PMC11038570  PMID: 2424596

Abstract

Effector mechanisms responsible for resistance against ectromelia virus including antiviral activity of non-immune macrophages, antiviral antibody, delayed footpad reaction to viral antigen, and interferon induction after viral infection were depressed in BALB/c mice bearing syngeneic Meth A tumor. The degree of viral growth correlated well with the depression of delayed footpad reaction, antibody production, and interferon induction. Therefore, modification of macrophage functions by a tumor-bearing state and treatment with PSK may contribute to this modification of antiviral resistance, at an early phase of infection. Cytotoxic activity may not be the principal effector, since the cytotoxicity was induced in normal and tumor-bearing mice to almost the same extent yet an extensive viral growth occurred only in the latter.

Keywords: Viral Infection, Interferon, Early Phase, Cytotoxic Activity, Antiviral Activity

References

  • 1.Abe S, Yamazaki M, Mizuno D. Correlation of differences in antigenecity of four 3-methycholanthrene-induced tumors in syngeneic mice with the susceptibility of tumors to immunopotentiator, PSK. Gann. 1978;69:223. [PubMed] [Google Scholar]
  • 2.Berlin BS. Sparing effect of X-rays for mice inoculated intranasally with egg-adapted influenza virus, CAM strain. Proc Soc Exp Biol Med. 1964;177:864. doi: 10.3181/00379727-117-29720. [DOI] [PubMed] [Google Scholar]
  • 3.Cole GA, Nathanson N. Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature. 1968;220:399. doi: 10.1038/220399a0. [DOI] [PubMed] [Google Scholar]
  • 4.De Gara PR, Furth J. The relative susceptibility of normal and X-rayed mice of different stocks to pneumotropic viruses. J Immunol. 1945;50:255. [Google Scholar]
  • 5.Gardner I, Bowern NA, Blanden RV. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. I. Specificity and kinetics. Eur J Immunol. 1974;4:63. doi: 10.1002/eji.1830040202. [DOI] [PubMed] [Google Scholar]
  • 6.Hurd J, Heath RB. Effect of cyclophosphamide on infections in mice caused by virulent and avirulent strains of influenza virus. Infect Immun. 1975;11:886. doi: 10.1128/iai.11.5.886-889.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kitani H, Tsuru S, Oguchi M, Watanabe M, Zinnaka Y. Effect of PSK on interferon production in tumor-bearing mice. J Clin Lab Immunol. 1984;15:211. [PubMed] [Google Scholar]
  • 8.Matsunaga K, Tsuru S, Morita I, Oguchi Y, Fujii T, Yoshikumi C, Hotta T, Nomoto K. Competitive effect of PSK against immunosuppressive factor obtained from tumor-bearing mice. Jpn J Cancer Chemother. 1980;7:496. [Google Scholar]
  • 9.Nakano Y, Taguchi T, Maeda T, Arakawa Y, Saito K. Influence of protein polysaccharide (PSK) on delayed hypersensitivity in tumor-bearing mice. Jpn J Cancer Chemother. 1974;1:131. [Google Scholar]
  • 10.Neumann C, Sorg C. Immune interferon. I Production by lymphokine-activated murine macrophages. Eur J Immunol. 1977;7:719. doi: 10.1002/eji.1830071014. [DOI] [PubMed] [Google Scholar]
  • 11.Nomoto K, Yoshikumi C, Matsunaga K, Fujii T, Takeya K. Restoration of antibody-forming capacities by PSK in tumor-bearing mice. Gann. 1975;66:365. [PubMed] [Google Scholar]
  • 12.North RJ, Kirstein DP, Tuttle RL. Subversion of host defence mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976;143:559. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Oguchi Y, Morita I, Ando T, Matsunaga K, Fujii T, Yoshikumi C, Hotta T, Nomoto K. Effect of PSK on generation of cytotoxic spleen cells against sarcoma 180 cells in tumor-bearing mouse. Proc Jpn Cancer Assoc. 1978;37:156. [Google Scholar]
  • 14.Ohno R, Imai K, Yokomaku S, Yamada K. Antitumor effect of protein-bound polysaccharide preparation, PSK, against 3-methylcholanthrene-induced fibrosarcoma in C57BL/6 mice. Gann. 1975;66:679. [PubMed] [Google Scholar]
  • 15.Ohno R, Yokomaku S, Wakayama K, Sugiura S, Yamada K. Effect of protein-bound polysaccharide preparation, PSK, on the immune response of mice to sheep red blood cells. Gann. 1976;67:97. [PubMed] [Google Scholar]
  • 16.Robinson TWE, Cureton RJR, Heath RB. The effect of cyclophosphamide on Sendai virus infection of mice. J Med Microbiol. 1969;2:137. doi: 10.1099/00222615-2-2-137. [DOI] [PubMed] [Google Scholar]
  • 17.Singer SH, Noguchi P, Kirschstein RL. Respiratory disease in cyclophosphamide-treated mice. II. Decreased virulence of PR 8 influenza virus. Infect Immun. 1972;5:957. doi: 10.1128/iai.5.6.957-960.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Thind IS, Price WH. Cross protection with group B arboviruses in mice treated with cyclophosphamide: role of serum antibody, viremia, and virus multiplication in the brain. Am J Epidemiol. 1968;89:89. doi: 10.1093/oxfordjournals.aje.a120919. [DOI] [PubMed] [Google Scholar]
  • 19.Thind IS, Price MH. Recovery from primary infection with E5 virus in normal and cyclophosphamide-treated mice: relative roles of virus multiplication, interferon, antibody and serum protective factor. Am J Epidemiol. 1969;89:593. doi: 10.1093/oxfordjournals.aje.a120972. [DOI] [PubMed] [Google Scholar]
  • 20.Tsukagoshi S, Ohashi F. Protein-bound polysaccharide preparation, PSK, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use. Gann. 1974;65:557. [PubMed] [Google Scholar]
  • 21.Tsuru S, Nomoto K. Effects of PSK on specific tumor immunity to syngeneic tumor cells. J Clin Lab Immunol. 1983;4:215. [PubMed] [Google Scholar]
  • 22.Tsuru S, Zinnaka Y, Nomoto K, Takeya K. Effects of cholera toxin on the lymphoid system. II. Selective augmentation of delayed footpad reaction in mice. J Clin Lab Immunol. 1981;6:185. [PubMed] [Google Scholar]
  • 23.Tsuru S, Kitani H, Seno M, Abe M, Zinnaka Y, Nomoto K. Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus. J Gen Virol. 1983;64:2021. doi: 10.1099/0022-1317-64-9-2021. [DOI] [PubMed] [Google Scholar]
  • 24.Tsuru S, Nomoto K, Taniguchi M, Kitani H, Watanabe M, Zinnaka Y. Depression of macrophage functions and T-cell-mediated immunity to listeria infection in tumor-bearing mice and its prevention by PSK. Cancer Immunol Immunother. 1984;18:169. doi: 10.1007/BF00205505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Werner G, Jentzsch U, Metzger E, Simon J. Studies on poxvirus infections in irradiated animals. Arch Virol. 1980;64:247. doi: 10.1007/BF01322704. [DOI] [PubMed] [Google Scholar]
  • 26.Yoshikumi C, Nomoto K, Matsunaga K, Fujii T, Takeya K. Mouse strain difference in the expression of antitumor activity of PSK. Gann. 1975;66:649. [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES